Novel Markers to Delineate Murine M1 and M2 Macrophages.
Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado Jde D, Popovich PG, Partida-Sanchez S, Guerau-de-Arellano M. · 2015
Read Novel Markers to Delineate Murine M1 and M2 Macrophages. by Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado Jde D, Popovich PG, Partida-Sanchez S, Guerau-de-Arellano M. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4689374.txt.
Introduction
Kyle A. Jablonski, Stephanie A. Amici, Lindsay M. Webb, and five colleagues searched for better markers of mouse macrophage types in PLoS ONE in 2015. Macrophages come in two broad states: M1, which fights microbes, and M2, which helps repair tissue. In real tissue the states blend, and the usual marker proteins are weak or shared. The team mapped gene activity across resting, M1, and M2 cells to find cleaner signals.
Two genes stood out on each side. CD38 and two partners marked M1 cells only, while Egr2 and c-Myc marked M2 cells only. Protein checks confirmed the split: CD38 labeled most M1 cells, and Egr2 labeled far more M2 cells than the standard marker did. The same CD38 pattern grew in living mice after an inflammatory trigger. The new markers give researchers sharper tools for telling these immune states apart.
Catalog record
| CREATOR | Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado Jde D, Popovich PG, Partida-Sanchez S, Guerau-de-Arellano M. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Novel Markers to Delineate Murine M1 and M2 Macrophages By Kyle A Jablonski, Stephanie A Amici, Lindsay M Webb, Juan de Dios Ruiz-Rosado, Phillip G Popovich, Santiago Partida-Sanchez, Mireia Guerau-de-Arellano, Michal A Olszewski Published in: PLoS ONE DOI: 10.1371/journal.pone.0145342 ABSTRACT Abstract Classically (M1) and alternatively activated (M2) macrophages exhibit distinct phenotypes and functions. It has been difficult to dissect macrophage phenotypes in vivo, where a spectrum of macrophage phenotypes exists, and also in vitro, where low or non-selective M2 marker protein expression is observed. To provide a foundation for the complexity of in vivo macrophage phenotypes, we performed a comprehensive analysis of the transcriptional signature of murine M0, M1 and M2 macrophages and identified genes common or exclusive to either subset. We validated by real-time PCR an M1-exclusive pattern of expression for CD38, G-protein coupled receptor 18 (Gpr18) and Formyl peptide receptor 2 (Fpr2) whereas Early growth response protein 2 (Egr2) and c-Myc were M2-exclusive. We further confirmed these data by flow cytometry and show that M1 and M2 macrophages can be distinguished by their relative expression of CD38 and Egr2. Egr2 labeled more M2 macrophages (~70%) than the canonical M2 macrophage marker Arginase-1, which labels 24% of M2 macrophages. Conversely, CD38 labeled most (71%) in vitro M1 macrophages. In vivo, a similar CD38+ population greatly increased after LPS exposure. Overall, this work defines exclusive and common M1 and M2 signatures and provides novel and improved tools to distinguish M1 and M2 murine macrophages. INTRODUCTION Macrophages help maintain homeostasis during embryonic development and throughout life [1–4]. The diversity and overlap of cues in the microenvironment can generate a spectrum of in vivo macrophage phenotypes and functions [3,5–11]. The classical (M1) and alternative (M2) activation macrophage phenotypes are thought to be at the extremes of this spectrum [7]. Release of pathogen or danger-associated molecular patterns (PAMPs or DAMPs) and IFN-γ during infection or tissue injury promotes classical macrophage activation and ensures tissue sterility [5]. In contrast, IL-4 produced by Th2 lymphocytes during immune responses to parasitic infections or allergens alternatively activates macrophages, promoting wound healing and repair [12–14]. Efficient M1 macrophage responses are important for ensuring resistance to bacterial infection and are elicited by both gram-positive and gram-negative bacteria [5] to control pathogen growth [15–17]. Therefore, many pathogens such as Salmonella, Brucella and Mycobacterium have evolved mechanisms that interfere with M1 polarization [18–22]. Conversely, excessive or unresolved M1 macrophage activation can cause chronic inflammation and tissue damage [23]. Indeed, M1 macrophages have been implicated in the pathogenesis of several inflammatory conditions including atherosclerosis, diabetes and glomerulonephritis [4,14]. In the nervous system, M1 macrophages have been associated with multiple sclerosis, amyotrophic lateral sclerosis, stroke, spinal cord injury and traumatic brain injury [24–28]. A switch from M1 to M2 macrophages is thought to occur during natural resolution of inflammation and M2 macrophages are less toxic to microbes and vulnerable post-mitotic host cells (e.g., neurons). As a result, M2 macrophages are often described as having anti-inflammatory or reparative functions. However, like M1 macrophages, excessive or uncontrolled M2 macrophage activity can also cause diseases such as fibrosis or asthma [29]. The involvement of macrophage phenotypes in disease implies that detecting or modulating macrophage responses could be diagnostically and/or therapeutically useful. However, advances in the field have been hampered due to lack of consistent nomenclature, suboptimal M1/M2 macrophage phenotype markers, and differences between in vivo and in vitro macrophages. A new nomenclature [11], which indicates the stimuli used for macrophage activation [e.g., M(IL-10)], should clarify macrophage nature and allow comparison between studies; however, it may not be feasible to use this nomenclature to describe macrophages in vivo where the nature of the stimuli are complex and often are unknown. Difficulty detecting M1 and M2 macrophage phenotype in vivo is compounded by similar problems in in vitro-derived macrophages. For example, Arginase-1, which is a considered a classic M2 marker, is also up-regulated in M1 macrophages [30,31] and protein expression of Arginase-1 or CD206 is too low for reliable flow cytometry detection [3,5–11,32]. In conclusion, a more robust M1 vs. M2-discriminating system is critically needed to improve the detection and understanding of macrophage phenotype. In vivo, CD38 revealed an endotoxemia-induced macrophage population. Overall, this work provides gene signatures and tools to define macrophage phenotype. Historically, M1/M2 marker discovery started in mouse macrophages using cDNA subtraction [7,30]. While this was followed by human macrophage transcriptome profiling [5,7,33–35], subsequent studies on mouse macrophages have deviated from clarifying shared and distinct M1/M2 signatures [12–14,36,37]. To provide a foundation for the complexity of in vivo macrophage phenotypes, we aimed to define the gene signatures associated with murine in vitro M1/M2 macrophage differentiation. Therefore, we performed transcriptional mRNA profiling in murine macrophages in either undifferentiated (M0), M1 or M2 conditions. The profiling data indicate that, as a result of different activation stimuli, M1 and M2 macrophages co-express many genes, referred to as shared signatures. For example, the shared signature showed increases in transcription factors (TF) Kruppel-like factor (Klf) 4 and Activating Transcription Factor (Atf) 4. However, M1 and M2-specific gene signatures were identified as well. Among the top distinct genes in M1 or M2 macrophages, we validated CD38, Gpr18 and Fpr2 as novel M1 markers and Egr2 and c-Myc as M2 markers. A CD38/Egr2-based flow cytometry assay was capable of distinguishing M1 and M2 macrophages and provided an advantage over classic iNOS, Arginase-1 and CD206 phenotype markers. In vivo, CD38 revealed an endotoxemia-induced macrophage population. Overall, this work provides gene signatures and tools to define macrophage phenotype. MATERIALS AND METHODS 2.1. Mice Wild-type (WT) mice on the C57BL/6J background (Jackson Laboratories) were bred and kept in specific pathogen-free conditions at The Ohio State University Laboratory Animal Resources. All animal experiment procedures were approved under Ohio State University’s IACUC protocol # 2009A0036-R1 or #2013A00000151 to ensure the humane care and use of animals. Euthanasia was performed by cervical dislocation after ketamine/xylazine anesthesia or C02 treatment. 2.2. Bone marrow derived macrophages (BMDM) To generate BMDM, the bone marrow cells from femurs and tibias from mice were harvested and cultured as previously described [5,28]. Briefly, isolated cells were incubated in Dulbecco’s Modified Eagle Media (DMEM, Mediatech, Herndon, VA) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Life Technologies, Grand Island, NY)), 1% penicillin/streptomycin, 1% glutamine, and 20% L929 cell supernatant (containing macrophage colony stimulating factor). On day 7 in culture the cells were washed, counted and replated in DMEM media (without L929 supernatant) at a density of 6-8x106 cells/well (6-well plate, Falcon polystyrene). Cells were classically activated (M1 condition) with LPS (100 ng/ml, Sigma-Aldrich L2880) + IFN-γ (20ng/mL, eBioscience, San Diego, CA), alternatively activated (M2 condition) with IL-4 (20ng/mL, eBioscience) or received media alone (M0 condition). The LPS+ IFN-γ condition is used to simulate infectious and/or autoimmune conditions in which Th1 cells produce IFN-γ while pathogens or tissue damage provide PAMPs or DAMPs, respectively. Cells were harvested at the indicated time points, generally 24 hours post-stimulation, by washing in phosphate buffered saline (PBS) before cell lysis in miRVana Lysis buffer (Life Technologies) for total RNA isolation. 2.3. In vivo inflammation For in vivo experiments, mice were injected with PBS or LPS (1 mg/kg, Sigma-Aldrich L2880). After 12 hours, mice were euthanized and spleen tissues were isolated